Komori
Japan Lifeline (7575) · PolicyReframed

Social contribution through providing patients with optimal medical devices

First written in FY2016. 5 of 10 entries say "Restated". Latest entry: FY2025.

10entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020ReframedFY2021 – FY2022AdvancedFY20232016: 120162017: 120172018: 120182019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 12025
Same theme, other companies
Improving Patient QOL Through Technological Innovation and Addressing Healthcare NeedsA theme 8 companies write about · 0 as a headwind · 9 as a tailwind

Japan Lifeline moved to the "Worse" side of this theme in 2021.

1 other company's latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025ReframedAnnual report

    「In March 2025, we reviewed our materialities to better reflect the social issues recognized by our group. Going forward, we will promote sustainability initiatives based on the seven newly identified materialities.」

    The company reviewed its previous seven materialities in March 2025 and reorganized them into seven new issues, including “Solving social issues through innovative medical devices” and “Promoting digitalization.”
  2. FY2025-H1RestatedAnnual report

    「Under these circumstances, to survive intense competition in the medical device industry, it is necessary not only to provide products with high therapeutic efficacy, but also to contribute to resolving the various challenges involved in achieving sustainable healthcare.」

    The company reiterated that, in addition to providing products with high therapeutic efficacy, it would contribute to resolving the challenges facing sustainable healthcare.
  3. FY2023AdvancedAnnual report

    「For each materiality, we have defined the desired state to be achieved by 2030 and established medium-term targets for the fiscal year ending March 2025 to realize that desired state.」

    The company established a desired state for 2030 and medium-term targets for the fiscal year ending March 2025 for each of the seven materialities, thereby providing a concrete framework for managing key issues based on its management philosophy.
  4. FY2022ReframedAnnual report

    「Our Seven Materialities (Key Issues)」

    The company’s contribution to patients and society under its management philosophy was organized into seven materialities. In addition to “Solving healthcare challenges through innovative medical devices,” the key issues include environmental impact, human resources, quality and stable supply, governance and compliance.
  5. FY2021ReframedAnnual report

    「Our management philosophy is to contribute to the realization of a healthy society through the latest and optimal medical devices.」

    The wording of the management philosophy was revised from the former “For people who are ill” to “Contributing to the realization of a healthy society.”
  6. FY2020RestatedAnnual report

    「Our management philosophy is to contribute to society by providing the latest and optimal medical devices for people who are ill.」

    The company reconfirmed contributing to society by providing patients with the latest and optimal medical devices as its management philosophy.
  7. FY2019RestatedAnnual report

    「Our management philosophy is to contribute to society by providing the latest and optimal medical devices for people who are ill.」

    The company reconfirmed contributing to society by providing patients with the latest and optimal medical devices as a management philosophy and a criterion for corporate activities.
  8. FY2018RestatedAnnual report

    「Our management philosophy is to contribute to society by providing the latest and optimal medical devices for people who are ill.」

    The company reconfirmed contributing to society by providing patients with the latest and optimal medical devices as a management philosophy and a criterion for corporate activities.
  9. FY2017RestatedAnnual report

    「Our management philosophy is to contribute to society by providing the latest and optimal medical devices for people who are ill.」

    The company reiterated contributing to society by providing patients with the latest and optimal medical devices as a management philosophy and a criterion for governance decisions.
  10. FY2016First statedAnnual report

    「Our management philosophy is to contribute to society by providing the latest and optimal medical devices for people who are ill.」

    Patients, compliance with laws and regulations, and business rationality are listed as criteria for making decisions in corporate activities.
Moved together

"Continued Cuts to Reimbursement Prices" moved the same way as this thread, in the same document, in 3 of its 10 moves.

333222★123456
  1. ★This thread
  2. 1Continued Cuts to Reimbursement Prices3×
  3. 2Obsolescence of Products Handled and Changes in Treatment Methods3×
  4. 3Decline in the Value of Loans to Business Partners and Equity Investments3×
  5. 4Absorbing Declines in Product Prices and Achieving Stable Growth2×
  6. 5Employees’ Pension Fund Underfunding2×
  7. 6Decline in Case Volumes Due to COVID-192×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Lifeline's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Social contribution through providing patients with optimal medical devices | Japan Lifeline Co.,Ltd. (7575) | Komori